Benedict Maliakkal

Benedict Maliakkal

University of Tennessee Health Science Center Memphis - Memphis / United States
Others
AD Scientific Index ID: 1639153
Universität Konstanz
person_outline Benedict Maliakkal's MOST POPULAR ARTICLES
1-) Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...The Lancet 394 (10215), 2184-2196, 20196782019
2-) Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failuresJS Bajaj, JG O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Leary, KR Reddy, F Wong, SW Biggins, H Patton, ...Hepatology 60 (1), 250-256, 20144232014
3-) Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosisPY Kwo, F Poordad, A Asatryan, S Wang, DL Wyles, T Hassanein, ...Journal of hepatology 67 (2), 263-271, 20173082017
4-) New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infectionF Wong, JG O\'Leary, KR Reddy, H Patton, PS Kamath, MB Fallon, ...Gastroenterology 145 (6), 1280-1288. e1, 20132812013
5-) NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosisJG O\'leary, KR Reddy, G Garcia‐Tsao, SW Biggins, F Wong, MB Fallon, ...Hepatology 67 (6), 2367-2374, 20182552018